← SynDRA
PALONOSETRON
SynDRA canonical compound SYN0022868 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | HTR3A |
|---|
| Mechanism of action | Serotonin receptor antagonist |
|---|
| Indication | nausea | vomiting |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR3A ANTAGONIST
- Serotonin 3a (5-HT3a) receptor antagonist
Drug classes
- Antiemetics
- Central Nervous System Agents
- Gastrointestinal Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Serotonin 5-HT3 Receptor Antagonists
- Serotonin Agents
- Serotonin Antagonists
- Serotonin 3 Receptor Antagonists
- Serotonin-3 Receptor Antagonist
ATC classes
- A04A · ANTIEMETICS AND ANTINAUSEANTS
Cross-references
Synonyms
- (-)-Palonosetron
- palonosetron hydrochloride
- aloxi
- RS 25259-197
- palonosetron HCl
- (-)-palonosetron
- Palonosetron, (3as, 3s)-
- NSC-743769
- Aloxi
- Onicit
- Palonosetron [INN]
- Aloxi (TN)
- RS-25233-197
- RS-25259-197
- (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one
- NSC 743769
- 5D06587D6R
- 2-Qhbiqo
- Palonosetronum
- CHEBI:85161
- RS 25233 198
- RS 25259 198
- RS-25259
- RefChem:56726
- DTXCID6028317
- A04AA05
- RS25259
- RS25233197
- RS25233198
- RS25259197
- RS25259198
- RS 25233197
- RS 25233198
- RS 25259197
- RS 25259198
- RS 25233 197
- MFCD07783848
- Palonosetron (INN)
Reported adverse events
- Constipation
- Dyspepsia
- Headache
- Hypersensitivity
- Asthenia
- Erythema
- Fatigue
Look up PALONOSETRON in the interactive SynDRA portal →